1. WHO WHO report on cancer: setting priorities, investing wisely and providing care for all; Geneva, 2020.
2. N.M. Tunissiolli, M.M.U. Castanhole-Nunes, P.M. Biselli-Chicote, É.C. Pavarino,, R.F. da Silva, R. da Silva, d. C. M. A., et al., Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pac. J. Cancer Prev. 2017, 18(4), 863-872.
3. Hepatocellular carcinoma: From diagnosis to treatment;Grandhi;Surg. Oncol.,2016
4. What are the advantages and disadvantages of imaging modalities to diagnose wear-related corrosion problems?;Nam;Clin. Orthop. Relat. Res.,2014
5. Suppression of the viability and proliferation of HepG2 hepatocellular carcinoma cell line by konjac glucomannan;Sawai;Anti-Cancer Agents Med. Chem. (Formerly Current Medicinal Chemistry-Anti-Cancer Agents),2019